Fundamental Analysis of Harrow Health Inc. 8.625% NT - Growth / Value Index


HROWL - Valuation Highlights

Valuation Analysis

   Tremendous increasing in Book Value last 3 year
   Tsr Value Index - Very Poor Score of 5.00
   Expensive - Price to Intrinsic Value of 2.78
   Price to Book Ratio of 21.33 suggesting that it is very expensive
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -26.85 -33.18 99.94 %
Price to Book 16.88 11.57 -99.96 % 14.63
Price to Sales 6.07 6.22 -99.93 %
Enterprise Value to EBITDA Multiple 0 57.01 100.05 %


HROWL - Profitability Highlights

Profitability Analysis

   Excellent QoQ /QoQ FY EPS growth
   Piotroski F Score - Stable Value of 4.0
   Tsr Profitability Index - Very Poor Score of 5.00
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -62.43 -34.70 32.03 % -22.40
Return On Asset -11.74 -7.83 12.52 % -4.59
Net Profit Margin -22.59 -18.75 -17.93 % -39.22
Operating Profit Margin -5.28 0.445 -79.43 % -20.03
EBITDA Margin -3.20 9.92 229.99 % -20.03


Highlights
Market Cap0
Enterprise Value0
Price/Book TTM16.88
Outstanding Share0
Float/ Outstanding Share%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score4.00
Altman Z Score-0.178
Sloan Ratio-0.091
Peter Lynch Fair Value0


HROWL - Growth Highlights

Growth Analysis

   STRONG JUMP IN NET SALE : YoY growth
   Tremendous increasing trend in total sale last 3 year
   Quarterly sales in last 5 years is trending up
   Steady increase in Total Assets for last 3 Years
   Tsr Growth Index - Poor Score of 29.01
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 138677 K 146852 % 4.86 %
Gross Profit 96755.00 K 143152 % 4.07 %
EBITDA -4444.00 K 191129 % 329.78 %
Net Profit -31333.00 K 173199 % 48.28 %
EPS -0.925 158773 % NA


HROWL - Stability Highlights

Stability Analysis

   Paid More Than 50% of Debt, Heading towards debt free
   Debt to equity ratio has decreased and is lowest in last five years
   Altman Z Score of -0.178 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of 0.0272
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.0115 -100.00 % 0.0131
Cash Ratio 1.68 -69.32 %
Quick Ratio 2.60 -56.67 % 2.75
Shareholders Equity 22.57 28.71 %
Debt to EBITDA 0.062 100.00 %


Historical Valuation Ratios of Harrow Health Inc. 8.625% NT

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Harrow Health Inc. 8.625% NT

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Harrow Health Inc. 8.625% NT

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Harrow Health Inc. 8.625% NT

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)